Five-Year Survival Rates

(from the National Cancer Institute's Physician Data Query system, July 2002)

Prognostic factors include grade of tumor, depth of myometrial invasion, and histology. High estrogen receptor levels have a favorable impact on prognosis.


Stage Survival Rate
Stage 0 100%
Stage I 70-95%
Stage II up to 55%
Stage III up to 25%
Stage IV up to 5%


Hydatidiform mole 100% (if treated properly).